- Home
- VERI vs BDTX Comparison
VERI vs BDTX Comparison
Compare VERI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERI
- BDTX
- Stock Information
- Founded
- VERI 2014
- BDTX 2014
- Country
- VERI United States
- BDTX United States
- Employees
- VERI N/A
- BDTX N/A
- Industry
- VERI EDP Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VERI Technology
- BDTX Health Care
- Exchange
- VERI Nasdaq
- BDTX Nasdaq
- Market Cap
- VERI 148.1M
- BDTX 106.4M
- IPO Year
- VERI 2017
- BDTX 2020
- Fundamental
- Price
- VERI $2.34
- BDTX $1.65
- Analyst Decision
- VERI Strong Buy
- BDTX Strong Buy
- Analyst Count
- VERI 3
- BDTX 5
- Target Price
- VERI $4.25
- BDTX $15.40
- AVG Volume (30 Days)
- VERI 623.7K
- BDTX 434.9K
- Earning Date
- VERI 03-13-2025
- BDTX 03-06-2025
- Dividend Yield
- VERI N/A
- BDTX N/A
- EPS Growth
- VERI N/A
- BDTX N/A
- EPS
- VERI N/A
- BDTX N/A
- Revenue
- VERI $124,881,000.00
- BDTX N/A
- Revenue This Year
- VERI N/A
- BDTX N/A
- Revenue Next Year
- VERI $2.94
- BDTX N/A
- P/E Ratio
- VERI N/A
- BDTX N/A
- Revenue Growth
- VERI 6.94
- BDTX N/A
- 52 Week Low
- VERI $2.03
- BDTX $1.59
- 52 Week High
- VERI $7.76
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- VERI 38.39
- BDTX 33.33
- Support Level
- VERI $2.23
- BDTX $1.59
- Resistance Level
- VERI $2.47
- BDTX $1.89
- Average True Range (ATR)
- VERI 0.21
- BDTX 0.15
- MACD
- VERI -0.03
- BDTX -0.03
- Stochastic Oscillator
- VERI 15.49
- BDTX 9.45
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel and India.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.